Home›Shop›CJC-1295 No DAC 10mg

CJC-1295 No DAC 10mg

Name: CJC-1295 No DAC 10mg
Brand: Nexora
SKU: CJC-1295-NO-DAC-10MG

Modified GRF 1-29

Batch: NX · Research reference material

Research Use Only

For laboratory research purposes only. Not for human consumption.

Premium Presentation

Produced with Nexora branded label artwork and secure packaging direction.

Documentation Roadmap

Batch verification and COA library are planned as the business scales.

€79.00

Tax included. Shipping calculated at checkout.

In Stock

Quantity

Research Information

Also known asModified GRF (1-29), MOD GRF (1-29)

ClassificationGrowth hormone releasing hormone (GHRH) analogue

FormatModified 29 amino acid GRF fragment

Product Overview+

CJC-1295 without DAC is a synthetic analogue of growth hormone releasing factor, commonly referenced in the literature as Modified GRF (1-29). It is one of the most frequently used reference compounds in laboratory work examining growth hormone signalling, receptor binding behaviour and endocrine regulatory pathways.

The compound is supplied as a sealed, lyophilised research vial. Lyophilisation preserves stability during storage and allows researchers to reconstitute the material under controlled conditions for in vitro experimentation.

Background and Scientific Context+

Interest in growth hormone releasing factors grew substantially through the late twentieth century as researchers worked to characterise the hormonal mechanisms governing growth hormone regulation. Advances in solid phase peptide synthesis then made it possible to produce modified GRF analogues with improved handling and stability characteristics suited to laboratory investigation.

Modified GRF (1-29) emerged from that body of work and has since become a widely cited reference compound in studies of receptor mediated signalling and endocrine regulation.

Mechanistic Focus in Research+

In controlled laboratory settings, CJC-1295 without DAC is studied in relation to peptide mediated signalling networks and receptor interaction dynamics. Common areas of experimental focus include:

Growth hormone releasing hormone receptor signalling
Peptide to receptor binding dynamics
Intracellular signalling cascades
Endocrine regulatory networks
Comparative analogue and structure activity models

Research Applications+

Within qualified research environments, this compound may be used in experimental models designed to investigate peptide signalling systems. Reported applications in the literature include:

Growth hormone signalling pathway research
Receptor interaction and binding studies
Endocrine system modelling
Cell signalling pathway analysis
Controlled in vitro comparative peptide research

Storage and Handling+

Store the sealed lyophilised vial cool, dry and protected from light. After reconstitution with a sterile diluent, keep the vial refrigerated and use within the working life indicated for the compound.

Handle as a laboratory reagent: clean workspace, appropriate personal protective equipment, and no contact with food preparation areas. Discard any material that is discoloured or contains visible particulates. Keep out of reach of children and away from unauthorised access.

Quality and Batch Traceability+

Every Nexora batch is assigned a unique NX code that is printed on the vial label and linked to its production record. That code can be entered on our Batch Verification page to retrieve the batch summary.

Our documentation programme covers identity confirmation, purity profiling and batch traceability, and a downloadable per batch Certificate of Analysis library is being rolled out as the catalogue scales. Analytical figures are published against real batch records rather than asserted in product copy.

Key Features+